Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of Preoperative Haemoglobin Level After Administration of Epoetin Alfa Associated With an Oral Versus Intravenous Iron Supplementation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02496377
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:02.350045+00:00
Published At
2019-01-23T00:00:00+00:00
Record Updated At
2019-01-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Allogenic Transfusion", "Perioperative Anaemia", "Knee Arthroplasty", "Hip Arthroplasty"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-01-23"
protocolSection.identificationModule.nctId
"NCT02496377"
protocolSection.identificationModule.officialTitle
"Comparison of Preoperative Haemoglobin Level After Administration of Epoetin Alfa Associated With an Oral Versus Intravenous Iron Supplementation"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Allogenic Transfusion (protocolSection.conditionsModule.conditions)
  • Perioperative Anaemia (protocolSection.conditionsModule.conditions)
  • Knee Arthroplasty (protocolSection.conditionsModule.conditions)
  • Hip Arthroplasty (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.